000 01230 a2200349 4500
005 20250515124838.0
264 0 _c20100402
008 201004s 0 0 fre d
022 _a1776-2561
024 7 _a10.1016/j.pneumo.2008.04.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBréchot, J-M
245 0 0 _a[Anemia and lung cancer].
_h[electronic resource]
260 _bRevue de pneumologie clinique
_cApr 2008
300 _a81-4 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAnemia
_xchemically induced
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aDisease Progression
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Administration Schedule
650 0 4 _aErythropoietin
_xadverse effects
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aQuality of Life
_xpsychology
650 0 4 _aRecombinant Proteins
650 0 4 _aRisk Factors
700 1 _aMorère, J-F
773 0 _tRevue de pneumologie clinique
_gvol. 64
_gno. 2
_gp. 81-4
856 4 0 _uhttps://doi.org/10.1016/j.pneumo.2008.04.002
_zAvailable from publisher's website
999 _c18072334
_d18072334